glp 1 medullary thyroid cancer GLP-1 medications and risk GLP-1 Receptor Agonists and Thyroid

Desire an FDA-approved, well-tolerated non-surgical weight loss treatment Who Should Not Use GLP-1 Medications These medications are not appropriate for patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2)

Specifically, a recent phase 2a clinical trial found reductions in body weight and improvements in glucose control but the degree of the improvements seemed to be within the range of what is seen with long-acting GLP-1r agonists alone (3, 189)

Gatto, A., Liu, K., Milan, N., & Wong, S

For those without insurance or with limited coverage, pharmaceutical companies sometimes offer savings programs, discount cards, or patient assistance programs that can significantly lower the cost of Semaglutide injections

This helps many patients lose weight and control blood sugar